In both breast cancer cell lines, SB203580 and SP600125 pre-treatment completely blocked PTER-ITC-induced PPARγ expression, whereas pre-treatment with PD98059 or DMSO had no effect (Fig. 8A). Here, PPARG is linked to breast cancer.